2006/07 Adult Treatment Plan

Download Report

Transcript 2006/07 Adult Treatment Plan

Kirklees DAAT
2006/07 Progress Report
2007/08 Draft Priorities
Kirklees PCT Board 29 August 2007
Tony Cooke
Senior Commissioning & Partnership Manager
DAAT Strategy Lead
Operating Environment August 2007
• Review of national drug strategy, though treatment agenda
unlikely to radically change
• Focus on CYP issues and U25 prevention via NICE guidance
• Improving evidence base, quality agenda and better
understanding of outcomes/impact
• Reducing budgets and ongoing unit costing exercises
• Annual needs assessments (2006/07 revealed 900 people
outside treatment, with 200 known to 5+ agencies)
• Stretch targets tightly managed by National Treatment Agency
• Joint NTA/Healthcare Commission inspections
• Renewed focus on alcohol interventions
• Majority of Kirklees offenders still have drug/alcohol problems
Strategic Priorities 2006/07
• Increasing numbers in treatment and increasing access from all
sections of the community
• Improving retention in treatment and successful completion of
treatment whilst further reducing waiting times, particularly for
offenders
• Introducing outcome monitoring system (Treatment Outcome
Profile)
• Improving harm reduction and BBV services
• Improving aftercare support and access to housing and
employment/training
• Further developing user and carer involvement and advocacy
where necessary
2006/07 NTA Performance Review
• 5 ‘core’ NTA targets, 4 green/1 amber
• Numbers in treatment up from 1816 (2005/06) to 1917 (07/08
target: 2,000)
• Retention at 12 weeks up from 68% to 76% (80%)
• Successful discharge up from 34% to 44% (52%)
• Number on care plan up from 79% to 90% (95%)
• Average wait just over one week (impact of nurse prescribers
and open access services)
• Ongoing performance improvements via case file audit,
improved clinical governance and effective performance
management
Healthcare Commission Inspections
• 2005/06 Inspection: Prescribing and Care Planning: 3 (top
quartile)
• 2006/07 Inspection: Commissioning and Harm Reduction: 4 (top
5 nationally)
• Commissioning: Particular strengths - performance
management, contracting, value for money, awareness of local
needs and overall ‘systems management’
• Harm reduction: Strengths - pharmacy services, strategic
management, drug related deaths
• Improvements needed: Response to Hepatitis C, approach to
Tier 4
Draft Priorities 2007/08
• Maintenance of broad strategic priorities
• Engineer shift towards primary care based provision with
specialist services reserved for most needy
• Dual diagnosis - joint developments PCT/SWYMHT
• Strengthen offender management systems with Police/Probation
whilst not detracting from health improvement agenda
• Improvements to CYP commissioning as advised by NICE
• SM commissioning strategy/embed agenda within CSD
directorate of PCT
• Refocus within DAAT to enable broader focus on ‘safer/stronger’
issues in partnership with KMC/Police/Probation
• Continue strong links to LPSBs/LAA
Summary
• Overall picture healthy but with fresh challenges emerging
• Many of strengths due to PCT role e.g. clinical governance
support/commissioning infrastructure
• Challenging targets stretched further and rate of improvement
may mean some targets not hit
• Risks created by reducing budgets - no fat left to trim
• Provider dissatisfaction at apparent ‘boom and bust’ - requesting
consolidation
• Still need for more integrated commissioning across adults,
criminal justice and young people’s provision